Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma
在早期滤泡性淋巴瘤的一项系统治疗随机试验中，辅助利妥昔单抗治疗和肿瘤内CD8表达升高与放疗后疾病的持续控制相关。
期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2024.105468
MacManus, Michael P; Seymour, John F; Tsang, Hennes; Fisher, Richard; Keane, Colm; Sabdia, Muhammed B; Law, Soi C; Gunawardana, Jay; Nath, Karthik; Kazakoff, Stephen H; Marques-Piubelli, Mario L; Duenas, Daniela E; Green, Michael R; Roos, Daniel; O'Brien, Peter; McCann, Andrew; Tsang, Richard; Davis, Sidney; Christie, David; Cheah, Chan; Amanuel, Benhur; Cochrane, Tara; Butler, Jason; Johnston, Anna; Shanavas, Mohamed; Li, Li; Vajdic, Claire; Kridel, Robert; Shelton, Victoria; Hershenfield, Samantha; Baetz, Tara; Lebrun, David; Johnson, Nathalie; Brodtkorb, Marianne; Ludvigsen, Maja; d'Amore, Francesco; Thompson, Ella R; Blombery, Piers; Gandhi, Maher K; Tobin, Joshua W D
